Literature DB >> 19475535

Oxidative stress, isoprostanes and hepatic fibrosis.

Mario Comporti1, Beatrice Arezzini, Cinzia Signorini, Daniela Vecchio, Concetta Gardi.   

Abstract

An introduction to oxidative stress enlightening the spreading of interest in lipid peroxidation in the 60's and in the identification of cytotoxic aldehydes originating from it is given. The discovery of F2-isoprostanes as specific markers of oxidative stress is described. Isoprostanes are also agonists of important biological effects. Since a relationship between oxidative stress and collagen hyperproduction has been previously suggested, and since lipid peroxidation products (aldehydes) have been proposed as possible mediators of liver fibrosis, we investigated whether collagen synthesis is induced by F2-isoprostanes, which can possess receptors for signal transduction pathways. In a rat model of carbon tetrachloride-induced hepatic fibrosis, plasma isoprostanes were markedly elevated for the entire experimental period and hepatic collagen content was also increased. Moreover, when hepatic stellate cells (HSC) isolated from normal livers were cultured up to activation and then treated with F2-isoprostanes (8-epi-PGF2alpha) in the concentration range found in the in vivo studies (10(-9) to 10(-8) M), a striking increase in DNA synthesis, in cell proliferation and in collagen synthesis was observed. F2-isoprostanes also increased the production of transforming growth factor-beta1 by U937 cells, assumed as a model of Kupffer cells or liver macrophages. The hypothesis that F2-isoprostanes generated by lipid peroxidation in hepatocytes mediate HSC proliferation and collagen hyperproduction, seen in this experimental hepatic fibrosis, was reinforced by the demonstration, by using immunoblot analysis, that isoprostane receptors identical or analogous to those for thromboxane A2 (TxA2r) are present in HSC. Immunocytochemical studies showed the major localization of TxA2r in the perinuclear site and its colocalization with alpha-smooth muscle actin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19475535     DOI: 10.14670/HH-24.893

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  11 in total

1.  Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells.

Authors:  Gabriella Horvath; Reka Brubel; Krisztina Kovacs; Dora Reglodi; Balazs Opper; Andrea Ferencz; Peter Szakaly; Eszter Laszlo; Lidia Hau; Peter Kiss; Andrea Tamas; Boglarka Racz
Journal:  J Mol Neurosci       Date:  2010-07-30       Impact factor: 3.444

2.  Comparison of Carotenoids for Their Antifibrogenic Effects in Hepatic Stellate Cells.

Authors:  Minkyung Bae; Mi-Bo Kim; Hyunju Kang; Young-Ki Park; Ji-Young Lee
Journal:  Lipids       Date:  2019-05-29       Impact factor: 1.880

3.  Oxidative stress in chronic liver disease: relationship between peripheral and hepatic measurements.

Authors:  Raj Vuppalanchi; Ravi Juluri; Lauren N Bell; Marwan Ghabril; Lisa Kamendulis; James E Klaunig; Romil Saxena; David Agarwal; Matthew S Johnson; Naga Chalasani
Journal:  Am J Med Sci       Date:  2011-10       Impact factor: 2.378

4.  CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury.

Authors:  Feng Bao; Arthur Brown; Gregory A Dekaban; Vanessa Omana; Lynne C Weaver
Journal:  Exp Neurol       Date:  2011-07-19       Impact factor: 5.330

5.  Thromboxane inhibitors attenuate inflammatory and fibrotic changes in rat liver despite continued ethanol administrations.

Authors:  Amin A Nanji; Emily C Liong; Jia Xiao; George L Tipoe
Journal:  Alcohol Clin Exp Res       Date:  2012-06-07       Impact factor: 3.455

6.  Antagonism of the thromboxane-prostanoid receptor is cardioprotective against right ventricular pressure overload.

Authors:  James D West; Bryan M Voss; Leo Pavliv; Mark de Caestecker; Anna R Hemnes; Erica J Carrier
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

7.  Antioxidant and hepatoprotective effects of silibinin in a rat model of nonalcoholic steatohepatitis.

Authors:  Yara Haddad; Diane Vallerand; Antoine Brault; Pierre S Haddad
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-12       Impact factor: 2.629

8.  An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study.

Authors:  Hao-Jie Zhu; Bryan J Brinda; Kenneth D Chavin; Hilary J Bernstein; Kennerly S Patrick; John S Markowitz
Journal:  Drug Metab Dispos       Date:  2013-07-08       Impact factor: 3.579

9.  Downregulation of NOX4 expression by roflumilast N-oxide reduces markers of fibrosis in lung fibroblasts.

Authors:  Daniela Vecchio; Alessandra Acquaviva; Beatrice Arezzini; Hermann Tenor; Piero A Martorana; Concetta Gardi
Journal:  Mediators Inflamm       Date:  2013-08-21       Impact factor: 4.711

10.  The Oxidative and Inflammatory State in Patients with Acute Renal Graft Dysfunction Treated with Tacrolimus.

Authors:  Sandra Carrillo-Ibarra; José Ignacio Cerrillos-Gutiérrez; Ariadna Escalante-Núñez; Enrique Rojas-Campos; Benjamín Gómez-Navarro; Sonia Sifuentes-Franco; Ernesto Germán Cardona-Muñoz; Alejandra Guillermina Miranda-Díaz
Journal:  Oxid Med Cell Longev       Date:  2016-10-30       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.